These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 7958469
1. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines. Schödel F, Kelly SM, Peterson D, Milich D, Hughes J, Tinge S, Wirtz R, Curtiss R. Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469 [Abstract] [Full Text] [Related]
2. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes. Schödel F, Peterson D, Hughes J, Wirtz R, Milich D. J Biotechnol; 1996 Jan 26; 44(1-3):91-6. PubMed ID: 8717391 [Abstract] [Full Text] [Related]
10. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B. Biochemistry (Mosc); 1998 May 15; 63(5):551-8. PubMed ID: 9632891 [Abstract] [Full Text] [Related]
11. Expression of hepatitis B virus antigens in attenuated Salmonellae for oral immunization. Schödel F, Will H. Res Microbiol; 1990 May 15; 141(7-8):831-7. PubMed ID: 2101472 [Abstract] [Full Text] [Related]
12. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response. Yang BF, Zhao HL, Xue C, Xiong XH, Zhang W, Yao XQ, Liu ZM. Vaccine; 2007 May 30; 25(22):4478-86. PubMed ID: 17467856 [Abstract] [Full Text] [Related]
13. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice. Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X. J Virol Methods; 2007 Apr 30; 141(1):41-8. PubMed ID: 17197041 [Abstract] [Full Text] [Related]
14. The hepatitis nucleocapsid as a vaccine carrier moiety. Milich DR, Peterson DL, Zheng J, Hughes JL, Wirtz R, Schödel F. Ann N Y Acad Sci; 1995 May 31; 754():187-201. PubMed ID: 7542855 [Abstract] [Full Text] [Related]
15. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Schödel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR. J Virol; 1992 Jan 31; 66(1):106-14. PubMed ID: 1370083 [Abstract] [Full Text] [Related]
16. Comparative immunogenicity of hepatitis B virus core and E antigens. Milich DR, McLachlan A, Stahl S, Wingfield P, Thornton GB, Hughes JL, Jones JE. J Immunol; 1988 Nov 15; 141(10):3617-24. PubMed ID: 2460543 [Abstract] [Full Text] [Related]
17. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo. Zhang Y, Song S, Liu C, Wang Y, Xian X, He Y, Wang J, Liu F, Sun S. Cell Immunol; 2007 May 15; 247(1):18-27. PubMed ID: 17707782 [Abstract] [Full Text] [Related]
18. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes. Schödel F, Wirtz R, Peterson D, Hughes J, Warren R, Sadoff J, Milich D. J Exp Med; 1994 Sep 01; 180(3):1037-46. PubMed ID: 7520465 [Abstract] [Full Text] [Related]
19. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice. Tindle RW, Herd K, Londoño P, Fernando GJ, Chatfield SN, Malcolm K, Dougan G. Virology; 1994 May 01; 200(2):547-57. PubMed ID: 7513919 [Abstract] [Full Text] [Related]
20. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus. Zhang YL, Guo YJ, Wang KY, Lu K, Li K, Zhu Y, Sun SH. Scand J Immunol; 2007 Apr 01; 65(4):320-8. PubMed ID: 17386022 [Abstract] [Full Text] [Related] Page: [Next] [New Search]